| Serial Number | 97047211 |
| Word Mark | EMESGEN |
| Filing Date | Monday, September 27, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 8, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 9, 2022 |
| Goods and Services | Pharmaceutical preparations for the treatment of infectious and parasitic diseases; Pharmaceutical preparations for the treatment of neoplasms; Pharmaceutical preparations for the treatment of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism; Pharmaceutical preparations for the treatment of endocrine, nutritional and metabolic diseases; Pharmaceutical preparations for the treatment of mental, behavioral and neuro developmental disorders; Pharmaceutical preparations for the treatment of diseases of the nervous system; Pharmaceutical preparations for the treatment of diseases of the eye and adnexa; Pharmaceutical preparations for the treatment of diseases of the ear and mastoid process; Pharmaceutical preparations for the treatment of diseases of the circulatory system; Pharmaceutical preparations for the treatment of diseases of the respiratory system; Pharmaceutical preparations for the treatment of diseases of the digestive system; Pharmaceutical preparations for the treatment of diseases of the skin and subcutaneous tissue; Pharmaceutical preparations for the treatment of diseases of the musculoskeletal system and connective tissue; Pharmaceutical preparations for the treatment of diseases of the genitourinary system, pregnancy, childbirth and the puerperium; Pharmaceutical preparations for the treatment of congenital malformations, deformations and chromosomal abnormalities |
| Goods and Services | Advertising, marketing and promotion services; Business consulting services; Business consultation and management regarding marketing activities and launching of new products; Business to business direct marketing services; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 26, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 26, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EMESGEN PHARMACEUTICALS |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Piscataway, NJ 08854 |
| Party Name | EMESGEN PHARMACEUTICALS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Piscataway, NJ 08854 |
| Event Date | Event Description |
| Monday, May 8, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, May 8, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, October 4, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 9, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 9, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 20, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 5, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, June 27, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, October 26, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 30, 2021 | NEW APPLICATION ENTERED |